CytomX Therapeutics
CTMX
CTMX
119 hedge funds and large institutions have $143M invested in CytomX Therapeutics in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 42 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 42
39% less capital invested
Capital invested by funds: $236M → $143M (-$93.1M)
Holders
119
Holding in Top 10
–
Calls
$63K
Puts
$34K
Top Buyers
| 1 | +$5.34M | |
| 2 | +$3.45M | |
| 3 | +$2.61M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.26M |
| 5 |
Renaissance Technologies
New York
|
+$1.04M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$5.16M | |
| 3 | -$4.11M | |
| 4 |
O
OrbiMed
New York
|
-$2.91M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.55M |